Trial intelligence / Profile preview

Dexmedetomidine and Lidocaine for Postoperative Inflammation in Laparoscopic Hysterectomy

NCT03276533Completed

Sponsor
Anqing Municipal Hospital
Start
Nov 2017
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine and Lidocaine Hydrochloride Injection, without epinephrine in post-operative inflammation, sponsored by Anqing Municipal Hospital. Started Nov 2017; status: completed.

02

Drugs

dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03

Conditions

post-operative inflammation

Beyond the preview

Go deeper on NCT03276533.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03276533.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call